Adma Biologics Inc

Market cap: $1,483,431,534

Exchange: NAS

Sector: Health Technology

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in the manufacturing, marketing and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.

Key Statistics

Company Name

Adma Biologics Inc

Average Volume (10 days)

2,572,235

Average Volume (30 days)

3,449,438

Moving Average (50 days)

$5.71

Moving Average (200 days)

$4.42

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

1,483,431,534

Shares Outstanding

228,220,236

52-Week High Split Adjust Only

6.62

52-Week Low Split Adjust Only

3.06

Employee Count

302

Beta

1.116

Next Earnings Date

2024-05-08

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

0.05%

Past 30 days

0.2%

Past 3 months

0.49%

Past 6 months

0.83%

Past year

0.96%

Past 2 years

2.99%

Past 5 years

0.94%

Max % Change

-0.23%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Adma Biologics IncADMAn/an/a-3.1n/an/a
Peer AvgN/A1318.5415.6621.01318.541309.22
Repligen Corp.RGEN23.156.4480.923.1521.51
Novavax, Inc.NVAX11.9010.53-18.011.9010.22
CEL-SCI CorporationCVM3920.5730.00n/a3920.573895.94